Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Given Consensus Rating of “Reduce” by Brokerages

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) has been assigned a consensus rating of “Reduce” from the nine ratings firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and eight have given a hold rating to the company.

Several equities research analysts have commented on BAYRY shares. Sanford C. Bernstein restated a “market perform” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, March 7th. Citigroup restated a “neutral” rating on shares of Bayer Aktiengesellschaft in a research report on Thursday, February 29th. Finally, Wolfe Research lowered Bayer Aktiengesellschaft from an “outperform” rating to a “peer perform” rating in a research report on Tuesday, January 30th.

Bayer Aktiengesellschaft Stock Down 0.2 %

BAYRY stock opened at $7.04 on Friday. The firm has a 50-day simple moving average of $7.44 and a two-hundred day simple moving average of $8.90. Bayer Aktiengesellschaft has a one year low of $6.96 and a one year high of $16.84. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.27 and a quick ratio of 0.80.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last posted its quarterly earnings data on Tuesday, March 5th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.12. Bayer Aktiengesellschaft had a negative net margin of 6.31% and a positive return on equity of 17.27%. The firm had revenue of $12.77 billion for the quarter. As a group, research analysts forecast that Bayer Aktiengesellschaft will post 1.36 earnings per share for the current year.

Bayer Aktiengesellschaft Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Monday, May 13th. Shareholders of record on Tuesday, April 30th will be issued a $0.0191 dividend. The ex-dividend date is Monday, April 29th. Bayer Aktiengesellschaft’s payout ratio is currently -54.88%.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.